Interim Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Mar. 27, 2015	Sep. 26, 2014
Current assets:
Cash and cash equivalents	$ 513,994	$ 568,472
Restricted cash	2,156	2,142
Short-term investments	188,164	231,208
Accounts receivable, net of allowance for doubtful accounts of $1,046 and $1,615	98,562	86,168
Inventories	23,761	8,536
Deferred taxes	80,858	86,445
Prepaid expenses and other current assets	34,523	22,880
Total current assets	942,018	1,005,851
Long-term investments	330,298	296,335
Property, plant and equipment, net	358,368	289,755
Intangible assets, net	106,369	63,700
Goodwill	312,869	277,574
Deferred taxes	55,340	41,746
Other non-current assets	9,342	9,051
Total assets	2,114,604	1,984,012
Current liabilities:
Accounts payable	14,130	15,898
Accrued liabilities	189,507	158,376
Income taxes payable	1,144	2,600
Deferred revenue	16,371	12,496
Total current liabilities	221,152	189,370
Long-term deferred revenue	29,678	19,279
Other non-current liabilities	64,715	43,715
Total liabilities	315,545	252,364
Stockholders' equity:
Additional paid-in capital	50,662	46,415
Retained earnings	1,739,346	1,660,485
Accumulated other comprehensive income	(7,532)	3,014
Total stockholders’ equity – Dolby Laboratories, Inc.	1,782,579	1,710,017
Controlling interest	16,480	21,631
Total stockholders’ equity	1,799,059	1,731,648
Total liabilities and stockholders’ equity	2,114,604	1,984,012
Class A, $0.001 par value, one vote per share, 500,000,000 shares authorized: 51,383,446 shares issued and outstanding at March 27, 2015 and 50,658,627 at September 26, 2014
Stockholders' equity:
Common stock	52	51
Class B, $0.001 par value, ten votes per share, 500,000,000 shares authorized: 51,073,661 shares issued and outstanding at March 27, 2015 and 51,610,239 at September 26, 2014
Stockholders' equity:
Common stock	$ 51	$ 52